Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

Allergan (AGN) needs VOS- from today's "New York Times"

"Indian Tribe Joins Big Pharma at the Supreme Court, Defending a Lucrative Deal"

https://www.nytimes.com/2019/01/26/us/politics/allergan-eye-drops-indian-tribe.html

Excerpts:

"Restasis, a treatment of chronic dry eye disease, had sales of nearly $1.5 billion in 2017 — Allergan’s best seller after Botox."

"Restasis sells in pharmacies for an average cash price of about $657 for a month’s supply,..."

That's nearly $8K per year, which seems insanely expensive.

Could be awesome if Allergan and/or Merck contact Aurinia re buying VOS.